INTRODUCTION
Imaging plays an important role in the management of gynecological diseases. There are three prime imaging modalities used in the assessment of female pelvis, namely Ultrasonography (USG), Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). 1 • Ultrasound is the primary modality of choice in diagnosing pathologies involving female pelvis.
• Computed Tomography reveals good bony details of the female pelvis.
• Magnetic Resonance Imaging yields good soft tissue details thereby better diagnosis. Ultrasound can be used as a screening modality for detecting pelvic malignancies. However it is inadequate in staging. CT and MR imaging are useful non-invasive tools for demonstrating anatomy and pathology of female pelvis. MRI is an important tool in detection and accurate staging in cases of cervical, endometrial and ovarian malignancies and plan the management accordingly. 2 However, investigating the patient with advanced modalities like CT or MRI before a prior ultrasound examination is not recommended because of the premature decision to expose the patient to radiation (in the case of CT) or the costlier investigation (MRI). It is a well-known fact that CT or MRI or combined use of USG with either of the modalities yield higher accuracy in the final diagnosis. 3 However, it should be borne in mind that ultrasound is still a sound enough preliminary imaging modality in detecting abdominal pathologies, especially female pelvic pathologies. 4, 5, 6, 7 Ultrasound being an initial investigating modality, in general confers the following advantages. 8, 9, 10 :
• The patient is never exposed to radiation during an ultrasound, allowing pregnant women to use this imaging technique.
• Most ultrasound exams are quicker.
• Less expensive.
• No known harmful effects to humans.
• If medically indicated it can be repeated again.
• Dynamic testing The major contribution of MRI in evaluating pelvic pathologies lies in its ability to determine whether a mass is truly ovarian in origin and to accurately identify certain benign entities e.g. dermoid cyst, endometriomas, hemorrhagic cysts and fibromas. It precisely defines the internal architecture of ovarian masses. 11, 12 Miscellaneous pelvic pathologies like teratoma, broad ligament fibroid, adenomyosis can be optimally diagnosed by MRI. MRI has an established role in the pre and post-procedural assessment for uterine artery embolization 13 , diagnosis of adenomyosis, staging of known endometrial and cervical carcinoma, evaluation of suspected Mullerian ductal anomalies 14 and pre-surgical workup for uterine prolapse. 15 Study aimed to assess the role of Ultrasound as an initial imaging technology in the assessment of pelvic pathologies with the objectives to perform ultrasound pelvis and MRI pelvis in women and to analyze and assess the significance of ultrasound and MRI in the evaluation of female pelvic pathologies.
MATERIAL AND METHODS
This was a retrospective study conducted in the department of radiology, Sri Ramachandra Medical College and Research Centre. The study was based on the usage of radiation-free modalities like ultrasound and MRI; hence no risks were posed to the patients in terms of radiation hazards.
The following imaging models were used: Ultrasound-GE LOGIQ P9, Magnetic resonance imaging-GE Signa HD XT 1. 
US and MR imaging protocols
Curvilinear probe (wide-band convex array) of 5.5 MHz frequency was used. MR imaging was performed with a 1.5-T MR imaging unit (Magnetom Avanto; GE Signa) using a 12-phased-array body coil. Patients were positioned in the supine position with arms raised above. Centering was placed on iliac crest. Contrast-enhanced MRI was done in patients who posed diagnostic dilemma with plain MR.
Inclusion criteria
Women of all age group
Exclusion criteria
• First trimester pregnancy • Claustrophobic patients • Metallic implants of less than 6 months duration
RESULTS
The results of the study are illustrated in tables 1 and 2. Pelvic ultrasound and MRI of 50 patients were analyzed. Of these 50 patients with pelvic pathologies, the ultrasound study picked up pathologies in 45 patients. The MRI study picked ultrasonography of pelvis by itself, successfully picked up 90% of the lesions (45/50 * 100 = 90%), which MRI did. A modality with 90% accuracy is considered one deemed worthy of the title "screening modality". Figure 1 shows abdominal USG and MRI images of a 33-year-old woman with complaints of menorrhagia and abdominal pain for the past 3 months. Clinically she had a On ultrasonographic imaging, a large para-ovarian cyst was noted on the right side. Proceeding with MRI, the cyst showed hemorrhagic components within and around the cyst, providing a refined diagnosis of ruptured hemorrhagic cyst. Figure 3 shows abdominal USG and MRI images of a 17-year-old girl with presenting complaints of secondary amenorrhea for 4 months. Clinical examination was normal. In USG, she was diagnosed to have a large well-defined heterogeneous lesion in the midline with communication with the left ovary. Her MRI pelvis revealed an enlarged left ovary which shows peripherally placed follicles with hematoma in the center, indicating left ovarian hemorrhagic cyst.
DISCUSSION
This retrospective study done on 50 patients showed that both Ultrasound and MRI are instrumental in female pelvic imaging. It was observed that the findings on MRI and ultrasound correlated in 45 patients. Various confounding factors such as partially distended urinary bladder (causing the formation of poor sonographic window), high BMI and excess bowel gas formation also lead to the minimal inaccuracy in the ultrasound study, indeed. The accuracy of this study could be improved by repeating the study on a mass scale, with well prepared bowel and adequately distended urinary bladder.
In the 23 of the 45 patients (51.1%), ultrasound and MRI had variable findings with more significant imaging findings on MRI with better image characterization, whereas in the remaining cases (48.9%), MRI findings concurred exactly with those of the ultrasound. This has also been the case for many previous studies as quoted below. Mitchell et al 16 , in his study has stated that in 83.3% of the cases (25 out of 30 cases) MR imaging yielded additional information such as demonstration of hemorrhage, fluidfluid level in the cysts, etc. Despite 85.7% of the teratoma (6 out of 7 cases) were diagnosed accurately just with US, the detection of fat in MR reinforced the diagnosis. Zawin et al 17 , in his study has stated that limited field of view was the single most major disadvantage of USG when compared to MRI. Also, US could not detect any of the 14 cases of submucosal leiomyoma. In his study, the minimum size of leiomyoma detected was comparable with both USG and MRI. It is indeed evident that MRI evaluated pelvic pathologies better due to its supreme ability in soft tissue characterization. It could precisely determine if a mass is truly ovarian in origin and sets apart the benign entities like hemorrhagic cysts from the malignant ones. MRI is a better tool for accurately staging and it can also aid in differentiating recurrence / residual mass in post-operative scanning. MRI throws an added advantage in pelvis imaging due to its lack of ionizing radiation, high contrast resolution, capability of viewing the entire pelvis, multiplanar imaging options and good tissue characterizing. Having mentioned the various advantages of MRI, however, ultrasound can still be considered as one of the efficient screening techniques for the detection of pelvic malignancies. Despite its inadequacy in being able to assess the staging, it plays a pivotal role in the evaluation of pelvic pathologies, as it is a dynamic study and can be repeated as many times as a radiologist needs. Technical advances, such as 3-D, color Doppler and real-time transvaginal dynamic US, make USG an effective imaging tool for gynecologic patients. The accuracy of US in picking up pelvic abnormalities is quite striking and also has a reasonably good level of characterizing the lesions. With the advent of contrast-enhanced ultrasonography, the role of US in assessing abdominal pathologies is even more crucial and vital.
CONCLUSION
Magnetic Resonance Imaging plays a pivotal role in characterizing female pelvic pathologies and therefore can be used as a problem-solving tool in patients when the ultrasound is inconclusive or suboptimal. However, the superior imaging potential of MRI should not preclude the use of ultrasound as a screening tool. Ultrasound remains the first line of imaging female pelvis, but, however, MRI should be considered for better evaluation and better characterization of pathologies when sonographic characteristics are not conclusive and also to determine the likelihood of malignancies. 
